Last reviewed · How we verify
Farletuzumab, Carboplatin, and PLD
Farletuzumab, Carboplatin, and PLD is a Small molecule drug developed by Morphotek. It is currently in Phase 1 development. Also known as: Farletuzumab (MORAb-003), Carboplatin, PLD.
At a glance
| Generic name | Farletuzumab, Carboplatin, and PLD |
|---|---|
| Also known as | Farletuzumab (MORAb-003), Carboplatin, PLD |
| Sponsor | Morphotek |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Participants With Low CA125 Platinum-sensitive Ovarian Cancer (PHASE2)
- Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin (PLD) to Treat Platinum-sensitive Ovarian Cancer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Farletuzumab, Carboplatin, and PLD CI brief — competitive landscape report
- Farletuzumab, Carboplatin, and PLD updates RSS · CI watch RSS
- Morphotek portfolio CI
Frequently asked questions about Farletuzumab, Carboplatin, and PLD
What is Farletuzumab, Carboplatin, and PLD?
Farletuzumab, Carboplatin, and PLD is a Small molecule drug developed by Morphotek.
Who makes Farletuzumab, Carboplatin, and PLD?
Farletuzumab, Carboplatin, and PLD is developed by Morphotek (see full Morphotek pipeline at /company/morphotek).
Is Farletuzumab, Carboplatin, and PLD also known as anything else?
Farletuzumab, Carboplatin, and PLD is also known as Farletuzumab (MORAb-003), Carboplatin, PLD.
What development phase is Farletuzumab, Carboplatin, and PLD in?
Farletuzumab, Carboplatin, and PLD is in Phase 1.
Related
- Manufacturer: Morphotek — full pipeline
- Also known as: Farletuzumab (MORAb-003), Carboplatin, PLD